Joseph Dowling

Chief Executive Officer

Mr. Dowling was appointed as our Chief Executive Officer ("CEO") on May 31, 2018 and Secretary on August 25, 2014. He was our Chief Financial Officer (“CFO”) from June 16, 2014 to March 15, 2019. Before joining CV Sciences, Mr. Dowling held numerous senior positions including serving as President and CFO of MediVas, LLC, a biotechnology company focused on drug formulation and delivery, from 2005 to 2013 where he led day-to-day operations, drug research and development, product development and commercialization and strategic alliance building, including license agreements with Pfizer, Merck, Wyeth, DSM, Guidant and Boston Scientific. Mr. Dowling served as a Managing Director in the mergers and acquisitions group at Citigroup from 1998 to 2005. Earlier in his career, Mr. Dowling served in various finance and accounting roles in both public accounting and in the banking industry. Mr. Dowling graduated from University of California, Los Angeles in Economics and is a Certified Public Accountant. As the Company’s Chief Executive Officer and former Chief Financial Officer, Mr. Dowling is specially qualified to serve on the Board because of his detailed knowledge of the pharmaceutical industry including drug research and development and the Company’s global consumer product operations and his expertise in financial matters.

Dr. Jamie Corroon Jr., ND, MPH

Director

Jamie Corroon, ND, MPH, is a licensed Naturopathic Doctor and Assistant Project Scientist at the Center for Medicinal Cannabis Research (CMCR) the University of California, San Diego (UCSD). He completed a postdoctoral fellowship in the Department of Family Medicine at UCSD, where he investigated the impact of cannabis use on cardiovascular health. Dr. Corroon earned a bachelor’s degree in Political Science from the University of Southern California, a master’s degree in Public Health (Epidemiology) from San Diego State University, and a Doctor of Naturopathic Medicine degree from Bastyr University. He serves as Medical Director at the Center for Medical Cannabis Education, advising dietary supplement and cannabis companies on science, regulation, and product development. Dr. Corroon is well-published in peer-reviewed literature, with recent publications examining the clinical and public health implications of society’s growing acceptance of cannabis. Dr. Corroon’s medical knowledge, independent judgment, and exceptional leadership skills make him an invaluable member of the Board..

Bill McCorkle

Director

Mr. McCorkle was appointed to our Board of Directors on October 21, 2022. Mr. McCorkle is an operational executive with over 30 years of experience solving problems with innovative solutions. Mr. McCorkle is experienced in managing day-to-day operations of small to large companies across multiple industries. Mr. McCorkle has held a variety of senior financial executive positions including CFO and COO of ISCA Inc., CFO, COO & Co-Founder of StemImmune Inc., CFO and COO of Genelux Corporation, and CFO and COO of Proformance Apparel Group, LLC.  Mr. McCorkle received a Bachelor of Science in Accountancy from Bentley University. Mr. McCorkle’s financial expertise, as well as his independence, judgment and exceptional leadership experience makes him a valuable addition to the Board.